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Introduction
Regulation of the paracellular permeability of the endothe-
lial cell (EC) monolayer is essential for the normal function 
of the vascular system, and its impairment has severe patho-
logical effects. VEGF and Ang1 (Angiopoietin-1) play es-
sential but opposite roles in the regulation of EC junctions 
and vessel permeability. The molecular mechanisms through 
which these ligands affect vessel permeability are known 
partially. VEGF increases vessel permeability by disrupting 
intercellular junctions through a signaling pathway that in-
cludes Src tyrosine kinase (Weis and Cheresh, 2005). Ang1, 
on the other hand, opposes the effect of VEGF by sequester-
ing Src (Gavard et al., 2008) and stabilizing intercellular 
junctions. In epithelial cells, junction stability is modulated 
by the apicobasal polarity complexes CRB (Crumbs–Pals–Patj), 
PAR (Par3–Par6–atypical PKC), and SCRIB (Scribble–Dlg–Lgl; 
Tepass, 1996; Qin et al., 2005; Dow and Humbert, 2007). The 
underlying molecular mechanism and the role of these polarity 
complexes in EC junction maintenance are unknown.
Rho GTPases constitute a major class of polarity protein 
and intercellular adhesion effectors (Fukata et al., 2003; Hall, 
2005; Iden and Collard, 2008). Junction homeostasis appears to 
require a precise level of RhoA activity: both hyper- and hypo-
activation of RhoA increased paracellular permeability (Braga 
et al., 1997; Popoff and Geny, 2009; Spindler et al., 2010). Fur-
thermore, the effect of RhoA on cell junctions depends on the 
agonist: RhoA stabilized junctions in response to Ang1 but de-
stabilized them in response to VEGF (Gavard et al., 2008). The 
regulation of RhoA by polarity complexes and its signaling at 
cell junctions are poorly understood.
Vascular endothelial growth factor (VEGF) and Ang1 (Angiopoietin-1) have opposing effects on vascular permeability, but the molecular basis 
of these effects is not fully known. We report in this 
paper that VEGF and Ang1 regulate endothelial cell (EC) 
junctions by determining the localization of the RhoA-
specific guanine nucleotide exchange factor Syx. Syx 
was recruited to junctions by members of the Crumbs 
polarity complex and promoted junction integrity by 
activating Diaphanous. VEGF caused translocation of 
Syx from cell junctions, promoting junction disassembly, 
whereas Ang1 maintained Syx at the junctions, induc-
ing junction stabilization. The VEGF-induced transloca-
tion of Syx from EC junctions was caused by PKD1 
(protein kinase D1)-mediated phosphorylation of Syx 
at Ser806, which reduced Syx association to its junc-
tional anchors. In support of the pivotal role of Syx in 
regulating EC junctions, syx/ mice had defective 
junctions, resulting in vascular leakiness, edema, and 
impaired heart function.
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uncovered an unexpected relationship between key members 
of the CRB polarity complex and the regulation of cell junc-
tions by Syx and RhoA. The localization of Syx, a previously 
unrecognized member of the CRB polarity complex, emerged 
as a key factor determining junction stability in vitro and 
vessel permeability in vivo and conferring the opposite effects 
of Ang1 and VEGF on EC junctions.
RhoA binds to and is activated by guanine nucleotide 
exchange factors (GEFs). We found that the RhoA-specific 
(De Toledo et al., 2001; Marx et al., 2005) synectin-binding 
RhoA exchange factor (Syx; Fig. 1 A) is localized to EC 
tight junctions (TJs). Syx is involved in EC migration (Liu 
and Horowitz, 2006) and regulates angiogenesis in both the 
zebrafish and mouse (Garnaas et al., 2008). In this study, we 
Figure 1. Syx associates with the CRB polarity complex, localizes at TJs, and is required for maintaining monolayer patency. (A) Schematic domain 
structure of Syx. DH, Dbl homology; PH, pleckstrin homology; BM, binding motif. (B) Overexpressed YFP-Syx and endogenous Syx colocalize with 
the cell junction marker ZO1 in confluent MDCK cells and HUVECs, respectively. The x-z and y-z sections correspond to the white lines. The nuclear 
staining in HUVECs is likely an artifact, as it is not removed by depletion of endogenous Syx (not depicted). (C) Scheme of the Syx protein complex. 
The TJ proteins are shown fainter to indicate that their association is inferred from other sources (Syn, synectin; Crbs, Crumbs). (D) Silencing efficacy 
of the syx shRNA constructs in HUVECs. (E) Effect of silencing endogenous Syx on ZO1 and F-actin (phalloidin) localization in HUVECs. (F) Effect 
of silencing endogenous Syx on the localization of VE-cadherin at the AJs of HUVECs. (G) Effect of silencing endogenous Syx on the localization of 
VE-cadherin (VE-cad) and ZO1 in HMVECs. (H) Time course of Syx depletion in HUVECs by shRNA1 expression. (I) Effect of silencing endogenous 
Syx on the impedance of a quiescent HUVEC monolayer. HUVECs infected with either nontarget (control [Ctrl] shRNA) or Syx shRNA1–expressing 
lentivirus were selected with puromycin for 18–24 h. 48-h postinfection cells were harvested, plated at high confluence (105 cells per well), and 
monitored for their impedance every 180 s for another 48 h (means ± SEM). (J) Quantification of nontargeted (control shRNA) versus Syx-depleted 
(Syx shRNA1) HUVEC number. 48-h postinfection cells were harvested and plated at equivalent confluence to cells in I (8 × 105 cells per well in 
a 6-well plate). The number of live cells was determined by trypan blue exclusion at 1 and 2 d after plating and normalized to the initial plating 
number. Bars: (B) 10 µm; (E–G) 20 µm.
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(Fig. 1 I). The difference in impedance between the two monolay-
ers cannot be attributed to cell density or cell death because cell 
numbers in each sample were very similar and remained so dur-
ing the 2 d of the assay (Fig. 1 J). This result indicates that Syx is 
required for the formation of a fully patent monolayer. Put to-
gether, these data indicate that Syx promotes intercellular junc-
tion stability and monolayer integrity.
syx/ mice have defective EC junctions and 
leaky vessels
We used the angiogenesis-deficient syx/ mouse (Garnaas 
et al., 2008) to study the in vivo role of Syx in cell junctions. Using 
ZO1 as a junction marker, we found that it was present as a con-
tinuous band in 80% of syx+/+ ECs but in <20% of syx/ ECs 
(Fig. 2, A and B), despite a similar expression level (Fig. 2 C). 
The impedance of syx/ EC monolayers increased at a lower 
rate than that of syx+/+ monolayers during the first 4 h and reached 
a plateau that was lower by 40% than the syx+/+ impedance at 48 h 
(Fig. 2 D). Cell numbers in the monolayers of each type were 
similar (unpublished data). This result indicates that junction 
formation by syx/ ECs is slower and that their junctions reach 
a lower steady-state patency compared with syx+/+ ECs. We then 
quantified vessel patency in vivo by measuring microsphere ex-
travasation from the tracheal venules of syx+/+ and syx/ mice. 
The latter was more than sixfold higher on average than that of 
syx+/+ mice (Fig. 2, E and F). Because the vasculature of the 
syx/ mouse is sparser than that of the syx+/+ counterpart (Garnaas 
et al., 2008), the higher extravasation from the syx/ vessels 
cannot be attributed to a larger vascular length or volume. To 
rule out the possibility that the leakiness of the syx/ venules 
reflected defects in non-EC types, we repeated the extravasation 
assays in a tie2-Cresyxfl/fl mouse model. Albeit lower than the ex-
travasation of syx/ venules, the extravasation from tie2-Cresyxfl/fl 
tracheal venules was more than sevenfold higher than in control 
syxfl/fl venules (Fig. 2, E and F). Using transmitted electron mi-
croscopy, we observed that the intercellular junctions between 
mural ECs of syx/ coronary capillaries were malformed or ab-
sent (Fig. 2 G). In syx+/+ mice, areas of intercellular contact be-
tween capillary ECs were closely juxtaposed and electron dense. 
On the other hand, ECs of syx/ capillaries had tenuous inter-
cellular contacts with reduced electron density or did not contact 
each other at all (Fig. 2 G). Furthermore, erythrocytes were pres-
ent in the interstitial space of the Syx/ myocardium (Fig. 2 H), 
consistent with other mouse models exhibiting morphologically 
similar junctional defects that also suffered from hemorrhage 
(Cattelino et al., 2003; Feng et al., 2006).
Edema can impair cardiac function by increasing the pas-
sive stiffness of the myocardium (Miyamoto et al., 1998; Fischer 
et al., 2006). To find whether the capillary leakage we observed 
affected the mechanical properties of the syx/ heart, we mea-
sured the pressure–volume relation in syx+/+ and syx/ left ven-
tricles subjected to partial aortic occlusion. The responses of the 
syx+/+ and syx/ left ventricles were vastly different: the differ-
ence between the end-diastolic and end-systolic volumes of the 
syx/ ventricle was much smaller (Fig. 2 I), resulting in a smaller 
ejection fraction. Because we found no structural differences at 
the sarcomere level between the syx+/+ and syx/ myocardia 
Results
Syx associates with cell junctions and  
is required for junction integrity
To identify novel regulators of Rho GTPases at cell junctions, we 
expressed a library of mammalian Rho GEFs in MDCK cells and 
screened it for junctional localization and for interaction with 
junctional proteins. Both endogenous and overexpressed YFP-
tagged Syx colocalized with ZO1 in human umbilical vein ECs 
(HUVECs) and in confluent MDCK cells, respectively (Fig. 1 B), 
indicating that it is a novel junctional Rho GEF.
Using immunoprecipitation of YFP-Syx followed by mass 
spectrometry analysis, we verified that Syx associated with the 
scaffold protein Mupp1 (multiple PDZ domain protein 1; Estévez 
et al., 2008; Ernkvist et al., 2009), synectin (also named Gipc1; 
Liu and Horowitz, 2006; Ernkvist et al., 2009), Lin7, and the pro-
tein associated with Lin7 (Pals1). We also found novel inter-
actions with 14-3-3 proteins; Fig. S1 A and Table S1). These 
associations, as well as the interaction of Syx with the Mupp1 
paralogue Patj (Pals1-associated with TJs), were verified by co-
immunoprecipitation and by colocalization of ectopically ex-
pressed or endogenous proteins in HUVECs and in neonatal 
human dermal microvascular ECs (HMVECs; Fig. S1, B–I). 
With the exception of 14-3-3, the association of these proteins 
depended on the C-terminal PDZ-binding motif (PBM) of Syx.
Several of the Syx-interacting partners are members of the 
apical CRB complex (Fig. 1 C), which promotes the integrity of 
intercellular junctions, as well as apicobasal polarity (Tepass, 
1996; Klebes and Knust, 2000; Shin et al., 2005). To determine 
whether Syx is a key member of this complex, we first tested 
whether it is required for TJ stability and function. Knockdown 
of either syx or mupp1 by each of two nonoverlapping shRNAs 
markedly reduced their expression level (Figs. 1 D and S2 B) 
and produced a fragmented ZO1 staining pattern in confluent 
HUVECs and HMVECs (Figs. 1, E and G; and S2, A–C).
The CRB complex has been implicated also in the stabil-
ity of adherens junctions (AJs), which are required for the main-
tenance of monolayer integrity (Tepass, 1996; Dejana et al., 2009). 
Mature AJs reorganize the cortical actin cytoskeleton into 
circumferential rings that are critical for monolayer integrity. 
We found that knockdown of syx in HUVEC monolayers abol-
ished the circumferential actin localization (Fig. 1 E) and 
reduced the localization of VE-cadherin to intercellular contact 
sites in HUVECs (Fig. 1 F) and in HMVECs (Fig. 1 G). The in-
creased distribution of VE-cadherin in the cytosol (Fig. 1 F) 
correlated with increased VE-cadherin endocytosis in Syx- 
depleted HUVECs (Fig. S2, D and E).
To determine the functional consequences of the observed 
junctional defects, we measured trans-endothelial impedance 
during the formation of postmitotic, confluent HUVEC mono-
layers expressing syx (Fig. 1 H) or control shRNA. The imped-
ance of both monolayers at 4,000 Hz climbed during the first 
20 h after plating, but from that point onward, the impedance of 
the syx shRNA-treated monolayer plateaued, indicating that it 
had achieved its maximum patency. In contrast, the impedance of 
monolayers treated by control shRNA continued climbing to a 
plateau higher by 30% than the syx shRNA-treated monolayers 
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Diaphanous (Dia) stabilizes cell junctions 
downstream of Syx
Previous studies have shown that Syx is a RhoA-specific GEF 
and that depletion of Syx in ECs results in a significantly re-
duced RhoA activity (De Toledo et al., 2001; Marx et al., 2005; 
Liu and Horowitz, 2006). Localized activation of RhoA at epithe-
lial AJs is important for junction assembly and maintenance 
(Terry et al., 2011). Therefore, we postulated that junction- 
localized Syx promotes junction stability. To test this premise, we 
used YFP-Syx, which we previously showed to activate RhoA 
at the cell membrane (Liu and Horowitz, 2006), and YFP-Syx-
PBM (Fig. S3 A), which induces RhoA activation in the cytosol 
(Fig. S2 F), the pressure–volume loop differences are unlikely 
to result from defective myocardial contractility. The aberrant 
pressure–volume relation of the syx/ left ventricle could have 
been caused, at least in part, by an alteration in the mechanical 
properties of the walls because of edema. We derived the pas-
sive stiffness of the left ventricle by calculating the slope of the 
linear approximation of the end-diastolic pressure–volume rela-
tion (Katz, 2006). The resulting passive stiffness of the syx/ 
ventricle was twice as high as that of the syx+/+ ventricle (Fig. 2 J). 
Therefore, our in vitro and in vivo results corroborate each 
other, showing that Syx is required for the maintenance of EC 
junctions and blood vessel patency.
Figure 2. Cell junction and heart defects in the syx/ mouse. (A) Confocal images of confluent monolayers of ZO1-immunolabeled (green) syx+/+ and syx/ 
ECs, acquired with the same imaging settings. Arrows point to appositions between syx/ ECs where ZO1 is absent. The framed regions are magnified in 
the insets. Bar, 50 µm. (B) Quantification of the percentage of ECs surrounded by ZO1 in fields of syx+/+ or syx/ ECs, each containing 65 cells (n = 10; 
±SEM; *, P < 1.010). (C) Expression levels of ZO1 in syx+/+ and syx/ ECs. The -actin immunoblot is a gel loading control of the ZO1 lanes. (D) syx+/+ and 
syx/ ECs were plated as confluent monolayers. Impedance at 4,000 Hz was measured every 180 s for 48 h (means ± SEM). (E) Images of syx+/+, syx/, 
syxfl/fl, and tie2-Cresyxfl/fl lectin-stained (red) tracheal venules injected with fluorescent microspheres (green, appearing yellow because of overlap with vessel 
walls). Arrows point to extravasated microspheres along the walls of syx/ vessels. Bar, 25 µm. (F) Relative values of extravasated bead fluorescence in im-
ages of tracheal vessels (n = 6; ±SEM; *, P < 0.009 and 0.0008). (G) Transmission electron micrographs of thin sections of syx+/+ and syx/ left ventricle 
myocardium. The junctions between ECs of syx+/+ capillaries are sealed, but EC junctions of syx/ capillaries are open or malformed. The framed regions 
are magnified below. Bars, 1 µm. (H) Images acquired as in G show that erythrocytes are enclosed within capillaries in the syx+/+ myocardium but are present 
in the interstitial space of the syx/ myocardium. Bars, 5 µm. (I) Representative series of pressure–volume loops measured in syx+/+ and syx/ left ventricles. 
Dashed lines denote end-diastolic pressure–volume relation (EDPVR) approximations, whose slopes (0.38 and 0.74 mmHg/µl in the syx+/+ and syx/ ven-
tricles, respectively) represent the passive stiffness of the ventricular wall. The data shown are from a single representative experiment out of three repeats. 
(J) syx+/+ and syx/ EDPVR slopes (means ± SD; n = 3; *, P = 0.015) normalized by the lowest slope of the syx+/+ EDPVR.
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overnight treatment with either Y-27632 or H1152 (10 µM) did 
not significantly affect junction integrity of control HUVECs, 
as assessed by ZO1 and actin staining (Fig. 3 A). Instead, ROCK 
inhibition partially restored junctional ZO1 and actin localization 
in HUVECs expressing syx shRNA (Fig. 3 A). Because ROCK 
activation cannot account for Syx effects at EC junctions, we 
next asked whether Dia stabilized junctions downstream of Syx. 
Dia is thought to prevent VE-cadherin endocytosis and to main-
tain junctional stability by inhibiting Src (Gavard et al., 2008). 
Similarly, Dia promotes E-cadherin stabilization and the estab-
lishment of a cortical actin ring in epithelial cells (Sahai and 
Marshall, 2002), downstream of RhoA (Carramusa et al., 2007). 
We found that expression of a constitutively active N-terminally 
truncated Dia1 mutant (Dia1N3; Watanabe et al., 1999) in cells 
depleted of endogenous Syx restored the junctional localization 
of ZO1 (Fig. 3 B). The Dia-mediated rescue of junctional ZO1 
staining was equivalent to that of rescuing Syx-depleted cells by 
expressing exogenous murine Syx (Fig. 3 C). Consistent with 
an involvement of Src in these effects, Syx depletion induced 
the activation of Src kinase (Figs. 3 D and S3 G, quantification), 
(Liu and Horowitz, 2006). Despite inducing equivalent levels of 
RhoA activation (Fig. S3 B), YFP-Syx localized at intercellular 
junctions and induced junctional actin accumulation (a telltale 
sign of mature AJs), whereas YFP-Syx-PBM was cytosolic 
and increased the number of stress fibers (Fig. S3, C and D). 
Furthermore, the N terminus region of Syx (Syx-N) inhibited 
the GEF activity of the endogenous Syx (Fig. S3 E and not de-
picted) and strongly suppressed junction formation when ex-
pressed at low levels, similar to the Rho selective inhibitor C3 
exotransferase (Fig. S3 F). These data argue strongly that Syx 
activates RhoA to promote junction integrity.
The regulation of intercellular junctions and permeability by 
RhoA is complex and is likely regulated by the subsequent activa-
tion of downstream effectors (Braga et al., 1997; Takaishi et al., 
1997; Sahai and Marshall, 2002; Wojciak-Stothard and Ridley, 
2002; Popoff and Geny, 2009; Terry et al., 2011). Signaling 
through the RhoA-associated kinases ROCK1 and ROCK2 has 
been related to both negative (Sahai and Marshall, 2002) and 
positive (Terry et al., 2011) effects on junction integrity. Sup-
pression of Rho-associated protein kinase (ROCK) activity by 
Figure 3. Dia1 rescues the effects of Syx depletion. (A) Effects of vehicle control, or ROCK inhibition (overnight) with 10 µM Y-27632 or 10 µM H1152 on 
ZO1 or F-actin (phalloidin) localization in nontarget (control [Ctrl] shRNA) versus Syx-depleted (Syx shRNA1) HUVECs. (B) Effects of transiently expressing 
YFP alone, YFP-tagged murine Syx (YFP-Syx), or YFP-tagged constitutively active Dia1 (YFP-Dia1N3) on ZO1 pattern in nontarget (control shRNA) versus 
Syx-depleted (Syx shRNA1) HUVECs. (C) Quantification of the percentage of HUVECs from B that express YFP constructs and are surrounded by a continu-
ous and linear ZO1 staining (means ± SEM; 10 cells per field; n = 6; **, P < 0.001). KD, kinase dead. (D) Effect of silencing Syx on Src phosphorylation 
at Y416 and total VE-cadherin (VE-cad) levels in HUVECs. (E) Effect of vehicle control or Src inhibition (10 min) with 1 µM PP2 on ZO1 localization in 
nontarget (control shRNA) versus Syx-depleted (Syx shRNA1) HUVECs. Bars: (A and E) 20 µm; (B) 10 µm.
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In contrast to Ang1, VEGF disrupts EC junctions (Olsson 
et al., 2006). In accordance, VEGF treatment (Fig. S4 C) had the 
same effect as depletion of Syx (Fig. 1, E and F) on VE-cadherin 
and ZO1 localization at cell junctions and on cortical actin 
organization. Strikingly, VEGF caused displacement of Syx 
from cell junctions at a time when the junctional ZO1 pattern 
became irregular, suggesting that TJs were disassembling (Figs. 5, 
D and E, quantification; and S4 G). Importantly, this loss of Syx 
from cell junctions was blocked by pretreatment for 15 min 
with Ang1 (Fig. 5, D and E). Ang1 pretreatment also prevented the 
VEGF-induced loss of junctional integrity, as reflected in the in-
creased accumulation of VE-cadherin and ZO1 at cell junctions. 
We also compared the relative impedance of quiescent HUVEC 
monolayers treated with PBS to those treated with VEGF, Ang1, or 
Ang1 together with VEGF. VEGF caused an early increase fol-
lowed by a sustained decrease in monolayer impedance (Fig. 5 F). 
Ang1 induced a small increase in impedance, probably because the 
monolayer had already reached full patency. Ang1 pretreatment 
(15 min) delayed and largely negated the VEGF effect during the 
60-min observation period, suggesting that barrier function closely 
correlates with Syx localization.
To test whether Syx regulates EC junctions in vivo, we 
compared the leakage of Evans blue dye from the skin of syx+/+ 
and syx/ mice in response to injections of PBS, VEGF-A165, 
or Ang1. The leakage of dye from the syx/ skin was more than 
threefold higher than the syx+/+ skin (Fig. 5 G). VEGF treatment 
did not further increase the leakiness of syx/ skin. Moreover, 
Ang1 was ineffective in diminishing the leakage from the syx/ 
skin, in contrast to the syx+/+ skin. The leakage from Ang1-
treated syx/ skin was close to ninefold higher than the leakage 
from syx+/+ skin. Therefore, the in vivo data are consistent with 
the sustained responses of our ECs in vitro to either VEGF or 
Ang1. Collectively, the data support a model whereby VEGF 
induces junction disassembly and increases monolayer permea-
bility by displacing Syx from the junctions, and conversely, 
Ang1 stabilizes junctions and sustains vessel patency at least in 
part by maintaining Syx at the junctions.
Phosphorylation downstream of VEGF and 
PKD1 regulates Syx localization
To determine whether VEGF induces the loss of junctional Syx 
by promoting its dissociation from Mupp1, we immunoprecipi-
tated endogenous Syx from control (PBS) or from VEGF-treated 
HUVECs. Fig. 6 A (quantitation of Mupp1 bands in Fig. S4 D) 
shows that less Mupp1 was coimmunoprecipitated by Syx in 
VEGF-treated cells. Further supporting the dissociation of Syx 
from Mupp1, VEGF treatment had little effect on the junctional 
localization of Mupp1 (Fig. S4, E and F). A clue to the mecha-
nism by which VEGF affects Syx localization came from the 
observation that PMA induced identical effects to VEGF on 
Syx localization and on ZO1 pattern in HUVECs (Fig. S4 G). 
As PKD is a critical downstream effector of both VEGF- and 
PMA-induced angiogenesis (Fig. S4 H; Taylor et al., 2006; 
Altschmied and Haendeler, 2008; Ha and Jin, 2009), we asked 
whether it regulates Syx-Mupp1 binding and alters Syx’s sub-
cellular localization. Using an antibody (pMotif) that recognizes 
PKD-phosphorylated motifs (Döppler et al., 2005), we detected 
and pharmacological inhibition of Src in Syx-depleted HUVECs 
partially restored the junctional localization of ZO1 (Fig. 3 E). 
Therefore, our data indicate that junction-targeted Syx is re-
quired for the localized activation of Dia by RhoA, resulting in 
the stabilization of intercellular junctions.
Syx acts downstream of CRB polarity 
members to regulate junction integrity
The interaction of Syx with members of the CRB complex and 
its localization to cell junctions require the C terminus PBM 
(Fig. S1, C–E). Synectin and Mupp1 bind directly to Syx via 
their PDZ domains in yeast two-hybrid screens (Liu and Horowitz, 
2006; Estévez et al., 2008; Ernkvist et al., 2009). Furthermore, 
Pals1 and Mupp1 interact directly via their L27 domains (Roh 
et al., 2002). Depletion of endogenous Mupp1 reduced the 
association of Syx with Pals1, without affecting binding of Syx 
to synectin (Fig. S4 A). In contrast, depletion of Pals1 did not 
affect the interaction of Syx with Mupp1 but reduced overall 
Mupp1 levels (Fig. S4 B), in agreement with the effect of Pals1 
on the stability of the Mupp1 paralogue Patj (Straight et al., 
2006). Similar to Syx, knockdown of Mupp1 also disrupted 
junction morphology (Figs. 4 A and S2, A–C). However, 
although depletion of Syx had little effect on the recruitment of 
Mupp1 to the remaining cell contacts, depletion of Mupp1 abol-
ished the junctional recruitment of either endogenous (Fig. 4 A) 
or exogenous Syx (Fig. 4 B). The data argue strongly that tar-
geting of Syx to EC junctions requires binding to Mupp1.
Consistent with the hypothesis that Syx acts downstream 
of the CRB polarity complex to promote junction stabiliza-
tion, depletion of Mupp1 induced the activation of Src kinase 
(Fig. 4 C). Similar to Syx-depleted cells (Fig. 3, A and E), in-
hibition of either ROCK or Src activities largely reversed the 
junctional defects of Mupp1-depleted cells (Fig. 4 D). Com-
bined, the data argue that Syx is a novel member and a key 
downstream effector of the CRB polarity complex in the regu-
lation of junction integrity.
Ang1 and VEGF reciprocally regulate the 
localization of Syx
Endothelial intercellular adhesion is regulated reciprocally 
by Ang1 and by VEGF. Because cell junction strengthening 
in response to Ang1 requires Rho-mediated activation of Dia, 
suppression of Src, and VE-cadherin stabilization (Gavard et al., 
2008), we tested whether Ang1-mediated junction stabiliza-
tion requires Syx. Ang1 treatment increased the localization 
of Syx at junctions (Fig. 5, A, D, and E, quantitation of Syx 
intensity at junctions). The junctional accumulation of either 
VE-cadherin or ZO1 (quantified in Fig. 5 B) was dramati-
cally disrupted in cells expressing syx-targeted shRNA and 
was not rescued by treating cells with Ang1. Consistent with 
this, Syx depletion prevented the Ang1-induced enhance-
ment of barrier function. The role of Syx in the regulation of 
barrier function by Ang1 was determined by measuring the 
impedance of postmitotic, confluent HUVEC monolayers treated 
by control or by syx shRNA. Whereas Ang1 increased the 
impedance of the control monolayers, it had no effect on the 
impedance of cells treated by syx shRNA (Fig. 5 C).
1109VEGF and Ang1 regulate cell junctions via Syx • Ngok et al.
(unpublished data). Finally, as with VEGF, the increase in Syx 
phosphorylation in response to PMA correlated strongly with 
decreased binding between Syx and Mupp1 (Fig. S5, F and G).
A potential PKD phosphorylation site was detected in Syx 
by deletion mutagenesis in the C terminus region beyond resi-
due 757 (Fig. S5 H). Sequence analysis identified two potential 
PKD phosphorylation motifs in that region, at Ser806 and Ser938 
(Fig. S5 I), whereas phosphopeptide mapping identified an addi-
tional site at Ser964. Mutation of Ser938 and Ser964 to Ala did not re-
duce recognition by the pMotif antibody upon PKD overexpression. 
Recognition was abolished, however, by mutating Ser806 to Ala 
selective phosphorylation of immunoprecipitated YFP-Syx but 
not of the other 21 Rho GEFs tested (Fig. S5 A). PMA treatment 
(Fig. S5 B) and overexpression of either wild-type or constitu-
tively active (but not kinase dead) PKD1 (Fig. S5 C) increased the 
phosphorylation level of Syx. Importantly, phosphorylation of 
YFP-Syx was blocked by silencing endogenous pkd1 and pkd2 
(Fig. S5 D). Consistent with these results and with the high 
level of PKD1 expression in HUVECs (Fig. S5 E), we observed a 
significant increase in Syx phosphorylation in VEGF-treated 
HUVECs (Fig. 6 B). Additionally, PKD1 colocalized with Syx 
at cell junctions and in the cytoplasm after VEGF treatment 
Figure 4. Syx acts downstream of Mupp1 to regulate junction integrity. (A) Effect of silencing Syx (Syx shRNA) on the localization of endogenous Mupp1 
and that of silencing Mupp1 (Mupp1 shRNA) on the localization of endogenous Syx in confluent HUVECs. ZO1, which colocalizes with Syx and Mupp1 
in control HUVECs expressing nontarget shRNA (control [ctrl] shRNA) is also shown as a measure of cell junction integrity. (B) Effect of expressing a mutant 
YFP-tagged murine Syx lacking the PBM (Syx-PBM) in control HUVECs expressing nontarget shRNA (control shRNA) or of expressing YFP-Syx in cells 
expressing Mupp1 shRNA on the targeting of ectopic Syx to the cell periphery. (C) Effect of silencing Mupp1 on Src phosphorylation at Y416 in HUVECs. 
(D) Effect of vehicle control, inhibition of ROCK (overnight) with 10 µM Y-27632, or inhibition of Src (10 min) with 1 µM PP2 on ZO1 localization in non-
target (control shRNA) versus Mupp1-depleted (Mupp1 shRNA1) HUVECs. Bars, 20 µm.
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full-length YFP-Syx or Syx carrying a S806A mutation from HeLa 
cells overexpressing PKD1. The amount of Mupp1 coimmunopre-
cipitated with Syx-S806A was approximately twice larger than 
the one coimmunoprecipitated with Syx (Fig. 6 C), confirming that 
S806 regulates Syx binding to Mupp1. When expressed in HUVECs, 
more cells expressing YFP-Syx-S806A exhibited junctional Syx 
localization than cells expressing YFP-Syx (Fig. 6, D and E). 
Importantly, VEGF treatment abolished the junctional localization 
of YFP-Syx but failed to significantly affect the localization of 
YFP-Syx-S806A at cell junctions (Fig. 6, D and E). These data 
indicate that phosphorylation of Syx at S806 is a major mechanism 
by which VEGF regulates the recruitment of Syx to EC junctions.
(Fig. S5 J). The possibility that another kinase acting down-
stream of PKD phosphorylates Syx at a classical PKD consen-
sus motif cannot be excluded by our data but is unlikely. The 
simplest explanation is that VEGF and PMA induce Syx phos-
phorylation at Ser806 by a common downstream effector, PKD, 
disrupting Syx binding to Mupp1 and, therefore, Syx localiza-
tion to cell junctions.
Because Syx phosphorylation correlated with reduced as-
sociation to Mupp1 (Figs. 6, A and B; and S5, F and G), we asked 
whether phosphorylation at Ser806 could regulate the binding of 
Syx to Mupp1 and thus affect the junctional localization and 
function of Syx. First, we used YFP as a tag to immunoprecipitate 
Figure 5. Ang1 and VEGF have opposing effects on Syx localization. (A) Effects of Angiopoietin-1 (Ang1) treatment (50 ng/ml for 45 min) on endogenous 
Syx, VE-cadherin (VE-cad), and ZO1 localization in nontarget (control [Ctrl] shRNA) versus Syx-depleted (Syx shRNA1) HUVECs. The nuclear ZO1 stain-
ing is an artifact of the rabbit antibody used here to visualize ZO1. (B) Quantification of the mean intensity of ZO1 at the junctions using ImageJ software 
(means ± SEM [error bars]; 30 cells per field; n = 6; **/++, P < 0.001, compared with control kinase dead + PBS). (C) Effects of Ang1 treatment on the 
impedance of Syx-depleted HUVEC monolayers. Nontarget (control shRNA) versus Syx-depleted (Syx shRNA1) HUVECs were grown in ECIS Cultureware 
Electrode Arrays for 48 h (as in Fig. 1I). Control (PBS) and Ang1 treatments were administered simultaneously as indicated, and impedance was mea-
sured every 180 s for the duration of the experiment. Results are representative of three independent experiments performed in triplicate. (means ± SEM). 
(D) Effects of Ang1 alone (45 min), VEGF alone (30 min), or cotreatment with Ang1 and VEGF (15 min with Ang1 followed by 30 min with VEGF) on 
Syx, ZO1, and VE-cadherin localization in HUVECs. (E) Quantification of the mean intensity of Syx at the junctions using ImageJ software and expressed 
as a percentage of control (PBS; means ± SEM; 10 cells per field; n = 6; **/++, P < 0.001, compared with PBS). (F) Effects of Ang1 alone (50 ng/ml), 
VEGF alone (50 ng/ml), or cotreatment with Ang1 and VEGF (15-min Ang1 pretreatment followed by VEGF, see arrows) on the impedance of quiescent 
HUVEC monolayers. Impedance values were normalized to the initial values at the beginning of the experiment and are plotted as relative impedance 
where the baseline value is set at 1.0 (means ± SEM). Results are representative of three independent experiments performed in triplicate. (G) Leakage 
of Evans blue dye from the skin of syx+/+ and syx/ mice in response to injections of PBS, 10 ng/ml VEGF-A165, or 50 ng/ml Ang1 as seen in images of 
the injections sites. The mean leakage in response to each type of injection is shown in the histogram (means ± SEM; n = 5). *, P < 0.05; **, P < 0.01; 
***, P < 0.001. Bars, 20 µm.
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The critical function of Syx in vascular homeostasis is 
highlighted by our observation that syx/ mice exhibit EC 
junction defects, vascular leakiness, edema, increased pas-
sive stiffness, and lower ejection fraction. Ang1 regulates 
vascular leakiness, vascularization, and inflammation as well 
as tumor cell intra- and extravasation (Suri et al., 1996; Thurston 
et al., 1999, 2000; Huang et al., 2010). The observation that 
Syx is required for Ang1-mediated stabilization of EC junctions 
in vitro and in vivo is therefore consistent with the increased 
leakiness and the decreased vascularization of syx/ mice 
(Garnaas et al., 2008) and raises questions as to the potential 
role of Syx in inflammation and/or tumor metastasis.
On the other hand, VEGF induces translocation of Syx and 
junction disassembly. By incorporating the new signaling events 
described here, PKD1 activation and phosphorylation of Syx at 
S806, we can delineate an entire VEGF signaling pathway ending 
in the disassembly of cell junctions: VEGF binding to VEGFR2 
(VEGF receptor 2) induces VEGFR2 autophosphorylation at 
Y1173, which promotes the binding of PLC and subsequent acti-
vation of a PLC–IP3 pathway, leading to enhanced extracel-
lular Ca2+ entry via the plasmalemmal store-operated channel 
Discussion
Here, we reveal a new signaling pathway that transduces both 
VEGF and Ang1 signaling and explains how these ligands in-
duce opposite effects on EC junctions and vessel permeability. 
The switch that determines the outcome of this pathway is the 
RhoA-specific GEF Syx. The removal of Syx from the junc-
tions downstream of VEGF results in their disassembly, whereas 
Ang1 stabilizes junctions by activating Dia through junction-
residing Syx. In addition to junction formation (Sahai and 
Marshall, 2002; Carramusa et al., 2007; Gavard et al., 2008), 
Dia reportedly also promotes focal adhesion turnover (Yamana 
et al., 2006). In agreement, silencing syx increased stress fiber 
density (Fig. 1 E), whereas ROCK inhibitors partially rescued 
junction defects induced by either Syx or Mupp1 depletion in 
confluent monolayers (Figs. 3 A and 4 D). These results are 
consistent with the antagonistic relationship between Dia and 
ROCK in junction maintenance (Sahai and Marshall, 2002) 
and suggest that Syx acts downstream of Mupp1 and the CRB 
complex to induce junction integrity by activating Dia and 
antagonizing ROCK (Fig. 7, proposed model).
Figure 6. VEGF and PKD1 regulate Syx binding to Mupp1 and targeting to cell junctions. (A) Coimmunoprecipitation of endogenous Syx with endogenous 
Mupp1 in HUVECs treated with either control PBS or VEGF (50 ng/ml for 30 min). (B) Detection of Syx phosphorylation at a classical PKD consensus motif 
by immunoblotting Syx immunoprecipitates from either PBS- or VEGF-treated cells with the pMotif antibody (pMotif). (C) Effect of the Syx S806A mutation 
on Mupp1 association. PKD1 was transiently coexpressed together with either YFP-Syx or YFP-Syx-S806A in HeLa cells. Syx was immunoprecipitated from 
cell lysates using a GFP-specific antibody, and either coprecipitated Mupp1 or PKD-mediated phosphorylation was detected using specific antibodies 
(Mupp1 and pMotif). (D) Effects of VEGF treatment (50 ng/ml for 30 min) on the localization of ZO1 and ectopically expressed YFP-Syx or YFP-Syx-S806A 
in HUVECs depleted of endogenous Syx (DAPI; blue). The framed regions of the merged image are also shown as separate YFP and ZO1 images to high-
light differences in Syx and ZO1 localization. Bars: (main images) 10 µm; (insets) 5 µm. (E) Quantification of the percentage of HUVECs transfected with 
YFP-Syx, or YFP-Syx-S806A in fields from D, exhibiting junctional Syx staining (means ± SEM [error bars]; 10 cells per field; n = 6; +, P < 0.01; **/++, 
P < 0.001). IP, immunoprecipitation.
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formation at the leading edge of migrating epithelial cells, down-
stream of RhoA and ROCK (Eiseler et al., 2009). Although this 
pathway has not been investigated in ECs, ROCK-activated PKD1 
could further disrupt endothelial junctions by displacing Syx.
Importantly, RhoA and Src signaling have been previ-
ously implicated in several physiological and pathological con-
ditions that depend on endothelial junction disassembly (Weis 
and Cheresh, 2005; Parikh et al., 2006; Gavard et al., 2008; 
Mackow and Gavrilovskaya, 2009). Maintaining the function of 
junctional Syx may therefore be therapeutically relevant in dis-
eases characterized by vascular leakiness and edema.
Materials and methods
Cells and transfection
Heart EC isolation from adult mice (8–16 wk) followed a previously pub-
lished technique (Dong et al., 1997). In brief, mouse hearts were minced 
and digested by collagenase I (Sigma-Aldrich). ECs were sorted by anti-
Pecam1 (BD) immobilized to magnetic beads (Invitrogen), expanded, and 
sorted again as before, producing a >95% EC-pure preparation. The HeLa 
and MDCK cells were cultured in DMEM (Cellgro) with 10% fetal bovine 
serum (Invitrogen). HUVECs and HMVEC-dermal neonatal (Lonza) were 
TRCP1 (transient receptor potential canonical-1; Jho et al., 
2005) and the subsequent activation of PKC- (Olsson et al., 
2006). The latter then activates PKD1 by phosphorylating S744 
and S748 on its activation loop (Wong and Jin, 2005). In turn, 
PKD1 promotes phosphorylation of Syx at S806, resulting in its 
dissociation from Mupp1 and translocation to the cytoplasm. 
Removal of junctional Syx reduces Dia activity, resulting in Src 
activation (Gavard et al., 2008), leading to increased phosphor-
ylation and destabilization of both AJ (Esser et al., 1998; Gavard 
et al., 2008) and TJ (Antonetti et al., 1999; Pedram et al., 2002) 
complexes, inducing junction disassembly (Fig. 7). Junction 
stability and barrier function are further compromised by in-
creased contractility, presumably because of Dia deactivation and 
the subsequent reorganization of F-actin away from cell junc-
tions, to focal adhesions and stress fibers (Yamana et al., 2006). 
Ang1 opposes VEGF-induced Ca2+ entry (Jho et al., 2005) and 
therefore PKC–PKD activation, thus providing a mechanistic 
explanation for its ability to retain Syx at the junctions.
PKD1 may act both upstream of RhoA by regulating 
Syx at the junctions and downstream of it by affecting actin 
dynamics. Indeed, PKD1 regulates F-actin–free barbed-end 
Figure 7. Schematic diagram of Syx ac-
tion at endothelial junctions. (left) Syx is 
recruited to endothelial junctions by Mupp1 
and forms a complex with multiple members 
of the CRB polarity complex (the asterisks 
denote a membrane receptor). This interaction 
is further promoted by Ang1 and results in 
the localized activation of RhoA and the 
selective activation of the Rho effector Dia. 
Dia induces junction stabilization, at least in 
part by suppressing the activities of Src and 
ROCK. (right) In contrast to Ang1, VEGF in-
duces the dissociation of Syx from Mupp1 
and its mislocalization away from cell junc-
tions through the PKD-mediated phosphoryla-
tion of Syx at Serine 806 (pS806). The loss of 
junctional Syx/RhoA/Dia signaling results in 
junction disassembly, through the unopposed 
activities of Src and ROCK. Junction destabili-
zation increases the permeability of confluent 
monolayers and induces vascular leakiness.
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Freshly infected HUVECs were harvested and replated in ECIS (electric cell-
substrate impedance system) chambers for impedance measurements of 
monolayer barrier function.
Immunofluorescence, immunoprecipitation, and immunoblotting
Cells were plated on coverslips (type I collagen coated for HUVECs; fibro-
nectin coated for HMVECs; BD), fixed with methanol or 3% paraformalde-
hyde as previously reported (Anastasiadis et al., 2000), and probed with 
primary antibodies followed by incubation with secondary antibodies. For 
HUVECs, 4 × 105 cells were resuspended in 100 µl EGM, plated on cover-
slips, and allowed to adhere for 5 min; for HMVECs, 2 × 105 cells were re-
suspended in 400 µl EGM-2MV, plated on coverslips, and allowed to 
adhere for 5 min. Medium was subsequently added into the wells, and the 
cell monolayer was maintained for 3 d before experiments were per-
formed. VE-cadherin internalization experiments were performed accord-
ing to Xiao et al. (2003). In brief, HUVECs were incubated in endothelium 
basal medium with anti–VE-cadherin (BV6) for 30 min at 4°C followed by 
antibody uptake for 30 min at 37°C in endothelium basal medium and 
then acid washed (10 min) to remove cell surface–bound antibody. Cells 
were then fixed and stained and then imaged at room temperature with a 
laser-scanning confocal microscope (LSM 510 META; Carl Zeiss) using 
Plan Neofluar 40×/1.3 NA or Plan Apochromat 63×/1.4 NA oil immer-
sion objectives. Raw images acquired at the same intensity and exposure 
settings with the ZEN 2009 software (Carl Zeiss) were analyzed for junc-
tional Syx or internalized VE-cadherin intensities using ImageJ (National 
Institutes of Health). Endogenous Syx was immunoprecipitated by a mouse 
monoclonal antibody (KIAA0720; Abnova). Protein samples were ana-
lyzed using SDS-PAGE, transferred to nitrocellulose, and probed with pri-
mary antibodies. Peroxidase-conjugated secondary antibodies (Jackson 
ImmunoResearch Laboratories, Inc.) were detected by luminescence 
(GE Healthcare).
Impedance measurement of endothelial barrier function
An electric cell substrate impedance system (ECIS Z; Applied BioPhysics) 
was used to measure the impedance of either HUVEC or primary mouse EC 
monolayers, as previously described in detail by Tiruppathi et al. (1992). 
In brief, cells (HUVECs, 105 cells/well; primary mouse ECs, 5 × 104 cells/
well) were plated in ECIS Cultureware Disposable Electrode Arrays 
(8W10E; Applied BioPhysics) precoated with collagen. After attachment to 
ECIS arrays, monolayers were allowed to adhere and become quiescent 
for 48 h. Treatments (PBS, VEGF at 50 ng/ml, and/or Ang1 at 50 ng/ml) 
were added directly into the wells at the indicated times. Impedance was 
measured every 180 s for the duration of the entire experiment. Impedance 
data at 4,000 Hz, representing current flow between the cells, are pre-
sented as is or normalized to the impedance value at the beginning of the 
experiment. Excel (Microsoft) was used for data analysis, and Prism 4 
(GraphPad Software) software was used for all graphing purposes. All 
data presented are representative of three independent experiments.
Rho activity assay
Rho activity was determined in HeLa cells using specific rhotekin pull-down 
assays (Cytoskeleton) for the activated form of the protein as previously de-
scribed (Soto et al., 2008). In brief, lysates of HeLa cells transfected with 
the respective constructs were cleared by centrifugation and incubated 
with 20 µg Rhotekin–Rho-binding domain beads (Cytoskeleton) for 1 h at 
4°C. Beads were then washed three times and eluted in boiling 2× Laemmli 
sample buffer, and the samples were analyzed by SDS-PAGE.
Electron microscopy
Mice anesthetized by 2.5% isoflurane were euthanized by injecting satu-
rated KCl solution. Mice were perfused by PBS, pH 7.4, through the ca-
rotid artery followed by 4% paraformaldehyde, which was washed out by 
PBS. Hearts were fixed by 15-min immersion in 3% glutaraldehyde, 2% 
paraformaldehyde, and 0.1 M cacodylate buffer, pH 7.4, containing 0.1 M 
sucrose and 3 mM CaCl2. Hearts were sliced into sections, fixed in same 
solution for 30 min, and cut down to 1-mm3 blocks followed by 24 h fixa-
tion at 4°C. Tissue blocks were fixed in 1% osmium tetroxide for 2 h and 
embedded in epoxy resin (Araldite; Sigma-Aldrich). Blocks were cut into 
6-µm sections on a microtome. Images were acquired on a transmission 
electron microscope (JEM-1010; JEOL).
Microsphere extravasation
Mice anesthetized by 100 mg/kg ketamine and 10 mg/kg xylazine were 
injected intraperitoneally by 100 IU heparin followed by 100 µl of 1:10 
diluted fluorescent 25-nm microspheres (Thermo Fisher Scientific) through 
cultured in EGM-2 (Endothelial Growth Medium-2) and EGM-2MV, respec-
tively (Lonza). HeLa and MDCK cells were transfected with TransIT-
HeLaMONSTER (Mirus Bio LLC) and Lipofectamine 2000 (Invitrogen), 
respectively, according to the manufacturer’s instructions. HUVEC’s were 
transfected with HUVEC Nucleofector kit (Amaxa) according to the manu-
facturer’s instructions.
EC-specific disruption of murine syx
LoxP sites flanking exons 10–16 (containing the catalytic Dbl homology 
domain of murine Syx) were inserted by homologous recombination. 
Heterozygous mice were crossed with germline Cre mice to excise the 
targeted region in all mouse tissues. Mice harboring EC-specific disrup-
tion of syx were obtained by crossing syx(loxP/loxP) and tie2-Cre (B6. 
Cg-Tg(Tek_cre)1Ywa/J; Jackson ImmunoResearch Laboratories, Inc.) mice.
Vectors, antibodies, and reagents
pEYFP-C1-mSyx, pEYFP-C1-mSyxPBM, N-terminally His-tagged mSyx trun-
cation mutants, RK5-myc-LIN-7 and RK5-myc-PATJ (provided by B. Margolis, 
University of Michigan, Ann Arbor, MI), pEGFP-mDia1N3 (provided by 
S. Narumiya, Kyoto University, Kyoto, Japan), and pCDNA3.1 HA-PKD 
wild-type, kinase-active, and kinase-dead constructs have been previously 
described (Kamberov et al., 2000; Ishizaki et al., 2001; Wang et al., 
2004; Döppler et al., 2005; Liu and Horowitz, 2006). Point mutations of 
serine to alanine were introduced into pEYFP-mSyx using multisite-directed 
mutagenesis kit (QuikChange; Agilent Technologies). mSyx truncation 
mutants were generated by cloning specific coding sequences (Syx N ter-
minus, amino acids 1–300; SyxNC, amino acids 291–800; SyxNter, 
amino acids 291–1,073) from pEYFP-mSyx into pEYFP-C1 using HindIII 
and BamHI as restriction sites. All constructs generated were sequenced to 
ensure no mutation was present.
The following antibodies were used: mouse anti-Plekhg5 (KIAA0720 
clone 5A9; Abnova); mouse anti–E-cadherin, anti-EEA1, and anti-Mupp1 
(BD); rabbit anti-Src (32G6), antiphospho-Src (Tyr416), and antimyc tag 
(Cell Signaling Technology); mouse anti-GFP 3E6, mouse anti-ZO1, mono-
clonal rabbit anti-GFP, and rabbit anti-ZO1 (Invitrogen); hamster and rat anti-
Pecam1 (Thermo Fisher Scientific and BD, respectively); rabbit anti–PKC-, 
anti–14-3-3, anti-Rho (26C4), anti-Pals1 (H-250), mouse anti-GIPC (C-9), 
goat anti–VE-cadherin (C-19; Santa Cruz Biotechnology, Inc.); mouse 
anti–VE-cadherin (BV6; EMD Millipore); mouse anti-FLAG, antipoly-Histi-
dine, and rabbit antiactin (Sigma-Aldrich ); and rabbit polyclonal antibody 
for pMOTIF was previously described (Döppler et al., 2005) as well as 
immunofluorescence-competent chicken anti–human Syx and rabbit anti-
Mupp1 (provided by R. Javier, Baylor College of Medicine, Houston, TX; 
Lee et al., 2000; Liu and Horowitz, 2006). Phalloidin 594 (Invitrogen) was 
used to stain for actin filaments in immunofluorescence experiments. DAPI 
was used to stain nuclei. Alexa Fluor 488 and Alexa Fluor 594 fluores-
cently conjugated secondary antibodies were obtained from Invitrogen 
and Jackson ImmunoResearch Laboratories, Inc.
PMA (Sigma-Aldrich) and PP2 (EMD Millipore) were dissolved in 
DMSO to 100 and 10 µM, respectively. Human recombinant VEGF was 
dissolved in sterile PBS to 10 ng/ml (EMD Millipore). Recombinant human 
Ang1 was dissolved in sterile PBS to 50 ng/ml (R&D Systems). Y-27632 
(Sigma-Aldrich) and H1152 (EMD Millipore) were dissolved in sterile 
water to 100 µM.
Affinity purification and mass spectrometry
YFP or YFP-tagged Syx was transfected into HeLa cells. Cell lysates were 
incubated with protein G beads (Invitrogen) precoated with anti-GFP (Invitro-
gen). Bound proteins were eluted, resolved by SDS-PAGE, and silver 
stained. Selected gel bands were destained, reduced, and alkylated before 
digestion with trypsin (Promega). Samples were analyzed using a hybrid 
mass spectrometer (ThermoFinnigan LTQ Orbitrap; Thermo Fisher Scien-
tific). Mascot (Matrix Science) was used to search the Swiss-Prot database 
to identify isolated peptides.
shRNA and lentivirus production
Lentiviral vectors (pLKO) encoding a nontarget shRNA sequence along with 
human-specific shRNA target sequences for Syx and Mupp1 were purchased 
(Syx RNAi 1, TRCN0000130291; Syx RNAi 2, TRCN0000128190; Mupp1 
RNAi 1, TRCN0000141979; and Mupp1 RNAi 2, TRCN0000145218; 
Thermo Fisher Scientific). 15 µg of packaging mix (ViraPower; Invitrogen) 
and 5 µg of the plasmid were transfected in 293FT cells (Invitrogen) 
using Lipofectamine 2000. 24 h later, the virus-containing media 
were harvested and used to infect HUVEC, HMVEC, or HeLa cells. Cells 
were selected with 2.5 µg/ml puromycin (Sigma-Aldrich) for 18–24 h. 
JCB • VOLUME 199 • NUMBER 7 • 2012 1114
Submitted: 2 July 2012
Accepted: 19 November 2012
References
Altschmied, J., and J. Haendeler. 2008. A new kid on the block: PKD1: a promis-
ing target for antiangiogenic therapy? Arterioscler. Thromb. Vasc. Biol. 
28:1689–1690. http://dx.doi.org/10.1161/ATVBAHA.108.174250
Anastasiadis, P.Z., S.Y. Moon, M.A. Thoreson, D.J. Mariner, H.C. Crawford, Y. 
Zheng, and A.B. Reynolds. 2000. Inhibition of RhoA by p120 catenin. 
Nat. Cell Biol. 2:637–644. http://dx.doi.org/10.1038/35023588
Antonetti, D.A., A.J. Barber, L.A. Hollinger, E.B. Wolpert, and T.W. 
Gardner. 1999. Vascular endothelial growth factor induces rapid phos-
phorylation of tight junction proteins occludin and zonula occluden 
1. A potential mechanism for vascular permeability in diabetic reti-
nopathy and tumors. J. Biol. Chem. 274:23463–23467. http://dx.doi 
.org/10.1074/jbc.274.33.23463
Braga, V.M., L.M. Machesky, A. Hall, and N.A. Hotchin. 1997. The small 
GTPases Rho and Rac are required for the establishment of cadherin-
dependent cell–cell contacts. J. Cell Biol. 137:1421–1431. http://dx.doi 
.org/10.1083/jcb.137.6.1421
Carramusa, L., C. Ballestrem, Y. Zilberman, and A.D. Bershadsky. 2007. 
Mammalian diaphanous-related formin Dia1 controls the organization 
of E-cadherin-mediated cell-cell junctions. J. Cell Sci. 120:3870–3882. 
http://dx.doi.org/10.1242/jcs.014365
Cattelino, A., S. Liebner, R. Gallini, A. Zanetti, G. Balconi, A. Corsi, P. Bianco, 
H. Wolburg, R. Moore, B. Oreda, et al. 2003. The conditional inactiva-
tion of the -catenin gene in endothelial cells causes a defective vascu-
lar pattern and increased vascular fragility. J. Cell Biol. 162:1111–1122. 
http://dx.doi.org/10.1083/jcb.200212157
Dejana, E., E. Tournier-Lasserve, and B.M. Weinstein. 2009. The control of 
vascular integrity by endothelial cell junctions: molecular basis and 
pathological implications. Dev. Cell. 16:209–221. http://dx.doi.org/ 
10.1016/j.devcel.2009.01.004
De Toledo, M., V. Coulon, S. Schmidt, P. Fort, and A. Blangy. 2001. The 
gene for a new brain specific RhoA exchange factor maps to the highly 
unstable chromosomal region 1p36.2-1p36.3. Oncogene. 20:7307–7317. 
http://dx.doi.org/10.1038/sj.onc.1204921
Dong, Q.G., S. Bernasconi, S. Lostaglio, R.W. De Calmanovici, I. Martin-
Padura, F. Breviario, C. Garlanda, S. Ramponi, A. Mantovani, and 
A. Vecchi. 1997. A general strategy for isolation of endothelial cells 
from murine tissues. Characterization of two endothelial cell lines 
from the murine lung and subcutaneous sponge implants. Arterioscler. 
Thromb. Vasc. Biol. 17:1599–1604. http://dx.doi.org/10.1161/01.ATV 
.17.8.1599
Döppler, H., P. Storz, J. Li, M.J. Comb, and A. Toker. 2005. A phosphoryla-
tion state-specific antibody recognizes Hsp27, a novel substrate of pro-
tein kinase D. J. Biol. Chem. 280:15013–15019. http://dx.doi.org/10 
.1074/jbc.C400575200
Dow, L.E., and P.O. Humbert. 2007. Polarity regulators and the control of epi-
thelial architecture, cell migration, and tumorigenesis. Int. Rev. Cytol. 
262:253–302. http://dx.doi.org/10.1016/S0074-7696(07)62006-3
Eiseler, T., H. Döppler, I.K. Yan, K. Kitatani, K. Mizuno, and P. Storz. 2009. 
Protein kinase D1 regulates cofilin-mediated F-actin reorganization and 
cell motility through slingshot. Nat. Cell Biol. 11:545–556. http://dx.doi 
.org/10.1038/ncb1861
Ernkvist, M., N. Luna Persson, S. Audebert, P. Lecine, I. Sinha, M. Liu, M. 
Schlueter, A. Horowitz, K. Aase, T. Weide, et al. 2009. The Amot/
Patj/Syx signaling complex spatially controls RhoA GTPase activity 
in migrating endothelial cells. Blood. 113:244–253. http://dx.doi.org/ 
10.1182/blood-2008-04-153874
Esser, S., M.G. Lampugnani, M. Corada, E. Dejana, and W. Risau. 1998. 
Vascular endothelial growth factor induces VE-cadherin tyrosine phos-
phorylation in endothelial cells. J. Cell Sci. 111:1853–1865.
Estévez, M.A., J.A. Henderson, D. Ahn, X.R. Zhu, G. Poschmann, H. Lübbert, 
R. Marx, and J.M. Baraban. 2008. The neuronal RhoA GEF, Tech, in-
teracts with the synaptic multi-PDZ-domain-containing protein, MUPP1. 
J. Neurochem. 106:1287–1297. http://dx.doi.org/10.1111/j.1471-4159 
.2008.05472.x
Feng, Y., M.H. Chen, I.P. Moskowitz, A.M. Mendonza, L. Vidali, F. Nakamura, 
D.J. Kwiatkowski, and C.A. Walsh. 2006. Filamin A (FLNA) is required 
for cell-cell contact in vascular development and cardiac morphogen-
esis. Proc. Natl. Acad. Sci. USA. 103:19836–19841. http://dx.doi.org/10 
.1073/pnas.0609628104
Fischer, U.M., C.S. Cox Jr., R.H. Stewart, G.A. Laine, and S.J. Allen. 2006. 
Impact of acute myocardial edema on left ventricular function. J. Invest. 
Surg. 19:31–38. http://dx.doi.org/10.1080/08941930500444438
the carotid vein. The microspheres were allowed to circulate for 2 min be-
fore the chest was opened. The vascular system was perfused with 1% 
paraformaldehyde/PBS, pH 7.4, through the left ventricle for 2 min at a 
constant pressure of 120 mmHg. The trachea was removed and incubated 
in 1% paraformaldehyde/PBS, pH 7.4, for 2 h at room temperature and 
then cut longitudinally and blocked by 3% BSA in PBS with 0.3% Triton 
X-100 for 1 h followed by anti-Pecam1 (Thermo Fisher Scientific) and fluor-
escently conjugated secondary antibody. Extravasation was measured by 
quantifying microsphere fluorescence in each image.
Leakage of dye from skin vessels (Miles assay)
Mice anesthetized as in the previous paragraph were injected through the 
tail vein by 200 µl Evans blue (0.5%). After 10 min, shaved areas on the 
flanks of each mouse were injected by 50 µl PBS, 10 ng/ml VEGF-A165, or 
50 ng/ml Ang1. After 20 min, mice were sacrificed by cervical disloca-
tion, and the skin around the sites of injections was dissected and flipped 
over to acquire digital images of dye leakage on the underside of the skin. 
The extent of leakage at each injection site was quantified from the images 
by Image-Pro (Media Cybernetics).
Pressure–volume measurements in the mouse
Mice positioned in dorsal recumbence were anesthetized with 2.5% isoflu-
rane in oxygen, intubated, and ventilated at 133 breaths per minute with 
a peak inspiratory pressure <20 cm H2O. Temperature was maintained at 
37.5°C. Lactated Ringer’s solution was delivered at 0.2 ml/h through a 
jugular catheter. A pressure–volume catheter (1.4 F; Millar Instruments) 
was inserted into the carotid artery, and the isoflurane was lowered to 
1.75%. Pressure and volume were recorded with the MPVS-400 system 
(Millar Instruments) and analyzed by PVAN software (Millar Instruments). 
Baseline carotid blood pressure was recorded at the reduced isoflurane 
level before introducing the catheter introduced into the left ventricle. Base-
line loops were recorded after a stabilization period of 20 min. A bolus 
of 2–3 µl of 9% saline was injected into the jugular vein. Pressure–volume 
loops generated immediately after saline injection were used to determine 
left ventricle conductance as part of the conversion to volume units. Isoflu-
rane levels were increased briefly to 2–2.25%, and a suture loop was 
placed on the transverse aorta. After a period of 10–15 min of stabiliza-
tion and reduced isoflurane, the loop was tightened, and the pressure and 
volume were recorded immediately. This was repeated to obtain at least 
four series of pressure–volume loops for calculation of the end-systolic and 
end-diastolic pressure–volume relationship.
Statistics
Statistical significance was analyzed by Student’s t test and expressed 
as a p-value.
Online supplemental material
Fig. S1 shows the interaction and colocalization of Syx with identi-
fied binding partners and the requirement of the PDZ-binding motif for 
these interactions. Fig. S2 shows the effects of Mupp1 and Syx deple-
tion on junction integrity of HUVECs and HMVECs and on VE-cadherin 
endocytosis in HUVECs, respectively. Fig. S3 shows that the localization 
of Syx at areas of cell–cell contact and RhoA activation are important 
for cell–cell adhesion. Fig. S4 shows the VEGF/PMA-induced translo-
cation of Syx away from junctions is caused by loss of Syx binding to 
Mupp1. Fig. S5 represents a series of experiments validating PKD-mediated 
phosphorylation of Syx at Ser806. Table S1 shows Syx-interacting pro-
teins. Online supplemental material is available at http://www.jcb.org/ 
cgi/content/full/jcb.201207009/DC1.
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